626 related articles for article (PubMed ID: 20512998)
1. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
La Mura V; Abraldes JG; Berzigotti A; Erice E; Flores-Arroyo A; García-Pagán JC; Bosch J
Hepatology; 2010 Jun; 51(6):2108-16. PubMed ID: 20512998
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
La Mura V; Abraldes JG; Raffa S; Retto O; Berzigotti A; García-Pagán JC; Bosch J
J Hepatol; 2009 Aug; 51(2):279-87. PubMed ID: 19501930
[TBL] [Abstract][Full Text] [Related]
3. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
[TBL] [Abstract][Full Text] [Related]
4. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No.
Thalheimer U; Bellis L; Puoti C; Burroughs AK
Eur J Intern Med; 2011 Feb; 22(1):5-7. PubMed ID: 21238884
[TBL] [Abstract][Full Text] [Related]
5. Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis.
Reverter E; Blasi A; Abraldes JG; Martínez-Palli G; Seijo S; Turon F; Berzigotti A; Balust J; Bosch J; García-Pagán JC
Liver Int; 2014 Jan; 34(1):16-25. PubMed ID: 23763484
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
Merkel C; Bolognesi M; Berzigotti A; Amodio P; Cavasin L; Casarotto IM; Zoli M; Gatta A
J Hepatol; 2010 Jan; 52(1):45-53. PubMed ID: 19914730
[TBL] [Abstract][Full Text] [Related]
7. Free Hepatic Vein Pressure Is Not Useful to Calculate the Portal Pressure Gradient in Cirrhosis: A Morphologic and Hemodynamic Study.
Rössle M; Blanke P; Fritz B; Schultheiss M; Bettinger D
J Vasc Interv Radiol; 2016 Aug; 27(8):1130-7. PubMed ID: 27212121
[TBL] [Abstract][Full Text] [Related]
8. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
9. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding? Yes!
Merkel C; Montagnese S
Eur J Intern Med; 2011 Feb; 22(1):1-4. PubMed ID: 21238883
[TBL] [Abstract][Full Text] [Related]
10. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding.
Monescillo A; Martínez-Lagares F; Ruiz-del-Arbol L; Sierra A; Guevara C; Jiménez E; Marrero JM; Buceta E; Sánchez J; Castellot A; Peñate M; Cruz A; Peña E
Hepatology; 2004 Oct; 40(4):793-801. PubMed ID: 15382120
[TBL] [Abstract][Full Text] [Related]
11. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Bellini B; Bighin R; Gatta A
Hepatology; 2000 Nov; 32(5):930-4. PubMed ID: 11050041
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension.
Escorsell A; Bordas JM; Castañeda B; Llach J; García-Pagán JC; Rodés J; Bosch J
Hepatology; 2000 May; 31(5):1061-7. PubMed ID: 10796880
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic response-guided therapy for prevention of variceal rebleeding: an uncontrolled pilot study.
González A; Augustin S; Pérez M; Dot J; Saperas E; Tomasello A; Segarra A; Armengol JR; Malagelada JR; Esteban R; Guardia J; Genescà J
Hepatology; 2006 Oct; 44(4):806-12. PubMed ID: 17006916
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis.
Turnes J; Garcia-Pagan JC; Abraldes JG; Hernandez-Guerra M; Dell'Era A; Bosch J
Am J Gastroenterol; 2006 Mar; 101(3):506-12. PubMed ID: 16542287
[TBL] [Abstract][Full Text] [Related]
15. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis.
Albillos A; Bañares R; González M; Ripoll C; Gonzalez R; Catalina MV; Molinero LM
Am J Gastroenterol; 2007 May; 102(5):1116-26. PubMed ID: 17391317
[TBL] [Abstract][Full Text] [Related]
16. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
17. Measurement of portal pressure.
Abraldes JG; Sarlieve P; Tandon P
Clin Liver Dis; 2014 Nov; 18(4):779-92. PubMed ID: 25438283
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
[TBL] [Abstract][Full Text] [Related]
20. Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers.
Hernández-Gea V; Aracil C; Colomo A; Garupera I; Poca M; Torras X; Miñana J; Guarner C; Villanueva C
Am J Gastroenterol; 2012 Mar; 107(3):418-27. PubMed ID: 22334252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
